Norwegian Armed Forces Medical Service — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Theophylline and BambuterolThis is a Phase I, three period, two sequence, open-label, randomized, crossover study, with the primary objective of testing the safety and tolerability of combined oral doses of theophylline and bambuterol in healthy human subjects. The secondary objective is to assess the pharmacokinetic profiles of theophylline and bambuterol when administered alone or in combination. It is hypothesized that the combination of these drugs is generally safe, and that no drug interaction can be observed.	SEP	Phase 1	À vérifier	Norway	À vérifier
Theophylline and BambuterolThis is a Phase I, three period, two sequence, open-label, randomized, crossover study, with the primary objective of testing the safety and tolerability of combined oral doses of theophylline and bambuterol in healthy human subjects. The secondary objective is to assess the pharmacokinetic profiles of theophylline and bambuterol when administered alone or in combination. It is hypothesized that the combination of these drugs is generally safe, and that no drug interaction can be observed.	SEP	Phase 1	À vérifier	Norway	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Theophylline and Bambuterol	SEP	Phase 1	NCT01566565	The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.